TPA (tumor promoter) --> bind to ProteinKinase C (involved in signallingtransmission) --> stimulate Mitogenic pathways
If an initiating mutation in a gene (e.g., proto-oncogene) enhances responsiveness to growth stimulation by a growth factor --> promoter might induce proliferation selectively in those initiated cells
Estrogen and estrogenic-mimetic chemicals: induce tumors in estrogen-dependenttissue
Studies on breast and ovarian cancer: individuals with high circulating estrogen levels + exposure to diethylstilbestrol (DES) (a synthetic form of estrogen) = increased risk of cancer development
DES was prescribed to pregnant women during 1940 - 1971 to prevent miscarriage and premature labor